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Abstract: Erythrosine (FD&C Red No.3, di
sodium
salt
of
2,4,5,7-tetraiodofluorescein); is used extensively as a
colour additive in foods, drugs and cosmetics.
Previous studies have shown that some of
the food additives, depending on their longterm and short-term use, have potential
carcinogenic, toxic and teratogenic effects. In
Turkey this colourant has temporary
permission of use until studies are completed
about it. In addition food colours may cause
allergic reactioıns due to food intolerance.
In our study 17 pregnant rats are divided
into two groups: control and erythrosine
group. 7 Wistar albino rats were
administered 5 ml erythrosine (2mg/ml) by
th
gavage at 7-8-9-10-11 days of their
pregnancy. 10 rats in positive control group
are given distilled water by gavage. At 20 th
day of pregnancy, pregnant rats in both
groups sacrificed by cervical dislocation and

Introduction
It is known that colourants have been using in foods,
drugs and cosmetics as an additive since B.C. 5000. In
order to make foods more delicious, protect and enhance
their eye appeal, food additives are added to foods,
however, they cause some reactions like urticaria,
angioneurotic edema and anaphylactic shock via spesific
mechanisms in sensitive individuals (1).
Erythrosine (FD&C Red No. 3), the sodium salt of
2,4,5,7-tetra iodofluorescein; is a member of xanthene
dyes and used extensively as a colour additive in foods. It
has been proposed that erythrosine may cause acute
toxicity and it has a tumor inducer property. The
WHO/FDA recommends an acceptable daily intake of 100
ppm for this additive (2).
According to certain animal experiments, erythrosine
causses extremely low acute toxicity, but has no effect
when administered chronically (3, 4). Erythrosine is not
genotoxic and therefore does not act as a tumor initiator
but perhaps it acts as a tumor promoter (4). However, in

laparotomy applied. Each live fetus was
promptly weighed and examined for
congenital anomalies and the crown-rump
lenght was measured. Routine fetal histologic
studies and light microscopic examination of
the sections stained with H&E was applied.
Mast cells are examined in the fetal dermal
sections stained with Toluidine Blue.
In erythrosine group, there were no
congenital defects, while the number of mast
cells of fetal skins were increased and
exocytosis was observed. This was
statistically significant (U=12 p<0.01**).
With respect of the previous studies, we
think that erythrosine may be one of the
causes of atopic diseases.
Key Words: Erythrosine (FD&C Red No. 3),
Food additives, Food colours, Atopy,
Teratogenicity.

various eucariotic systems (ascites tumor cells, chiniese
hamster liver cells, lymphocytes, erythrocytes, etc...)
erythrosine shows an ambigious genotoxic response (3).
Increase in the number of hypersensitive individuals
suggested that some of the factors influence pathogenesis
of allergy may be related to use of food additives. On the
other side, it is estimated that 1-5 percent of congenital
malformations observed in human is related to the use of
drugs and chemicals. Therefore, the aim of the present
study was to investigate the effects of erythrosine on rat
fetus in the means of teratogenity and atopic diseases.
Material and Methods
Chemical: Erythrosine (FD&C Red No. 3) 87% pure,
of certified food-grade quality was purchased from a
convenient food industrial.
Animals: 17 female Wistar albino rats, each 13-21
week age, 130-200 g body weight, were used. Animals
were housed in an environmentally controlled room (20-
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Control Group

Table 1.

Erythrosine Group

n

x

Sx

n

x

Sx

Before Pregnancy

10

173.50

9.60

7

200.00

0.00

After Pregnancy

10

264.50

10.71

7

312.86

6.44

Table 2.

Fetuse lengths of control and erythrosine groups (cm.)

Control
Eryhrosine Group

n

x

Sx

10
7

3.79
3.87

0.15
0.07

Body weight of control and
erythrosine group of pregnancies
(g).

formaline solution, embedded in paraffin blocks and 5µ
thick slides were prepared and stained with Haematoxylin
and Eosin (H&E) and to evaluate the distribution of mast
cells Toluidine Blue stain was used. In the subcutaneous
tissue of fetuses granulated and degranulated mast cells
were classified depending on their morphologic features
by Wingren and Enerbach’s score.
Semiquantitative grading of staining:

Table 3.

Fetuse weights of control and eryhrosine groups (g).

Control
Eryhrosine Group

n

x

Sx

10
7

3.78
4.11

0.37
0.18

0 point= no mast cells.
1 point= few, faintly metachromatic and mostly
immature mast cells.
2 point= in a normal number and almost all of them
degranulated mature and immature mast cells.
3 point= in a normal number, almost half of them

Scales

Control Groups
Erythrosine Group

1

2

3

4

5

1
6

220
6

93
47

2
51

101

18

21˚C, 40-60% relative humidity) and 12 hour light/dark
cycle and fed ad lib.
Experimental Procedure: On mating days two
females were randomly mated with one male at
approximately 4.30 p.m. The following morning, a
vaginal smear was obtained from each female to
determine whether copulation had taken place. Sperm
positive dams were considered to be at day 0 of
gestation. 10 pregnants served as controls and 7 served
as erythrosine group. In eryhrosine group, each animal
was treated daily, from day 7 to day 11, with the dose of
5 ml of the solution which has 2 mg/ml erythrosine
dissolved in distilled water by gavage. Controls were
received only 5 ml distilled water in the same time period.
On 20th day of gestation starting at 1 p.m., the females
were sacrificed by cervical dislocation. Laparotomy was
performed. The uterus was opened and examined in situ.
The uterine positions of all implantation sites were noted
and their condition (early or late resorption, living or
dead fetuses) was determined. Each live fetus was
promptly weighed and examined for congenital anomalies
the crown-rump length was measured.
Histology: Fetuses were fixed in 10% neutral
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Table 4.

0

Mast cell findings of control and
erythrosine groups (g.)

exocytosed mature mast cells.
4 point= in a high number, strongly metachromatic,
mostly granulated, few exocytosed mature
mast cells.
5 point= in a high number, strongly metachromatic,
almost all of them exocytosed mature mast
cells, diffused granules within tissue(5).
Statistical analysis: Mann-Whitney-U Test and t-test.
Results
Macroscopic Results:
Table 1 lists the findings of the control and
erythrosine groups before and after body weight of
pregnancy.
According to t-test, there was a significant difference
between control and erytrosine groups in the means of
body weights of mothers before pregnancy (t=-2.29
SD=15 p<0.05*).
According to t-test, there was a significant difference
between control and eryhrosine groups in the means of
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body weights of mothers after pregnancy (t=-3.46
SD=15 p<0.01**).
There was no significant difference between control
and erythrosine groups fetuses in the means of crownrump lenght (t=-0.43 SD=15 p>0.05) (Table 2).
According to t-test, there was no significant difference
between control and erythrosine group fetuses in the
means of fetuses weights (t=-0.72 SD=15 p>0.05)
(Table 3).
Microscopic Results:
The development of nervous system, face, skull,
skeleton, endocrine, cardiovascular, respiratory, digestive,

Figure 1.

A number of mast cell (→) in
dermis of control group Toluidine
Blue.

Figure 2.

Mast cells including few numbers
of granules in dermis of control
group. Toluidine Blue.

urogenital systems and sensory organs was evaluated on
series of sections stained with H&E. Our results showed
that there was no difference between control and
erythrosine groups.
In order to determine the number of the mast cells in
fetal subcutaneous tissues, the distribution of mature and
immature mast cells, the presence of granulation and
degranulation of these cells and the diffusion of these
granules within tissues, the slides stained with Toluidine
Blue were evaluated. According to our results in the
fetuses subcutaneous tissues of control group, there were
a few number of immature mast cells (Fig. 1, 2). In the
fetuses of eryhrosine group subcutaneous sections mast
cell numbers and degranulation intensity increased were
determined (Fig. 3, 4). This differences between control
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and erythrosine groups were evaluated according to
semiquantitative grading as described before (5, 6, 7).
According to Mann-Whitney U Test results done for
non-parametric values, there was a significant difference
between control and erythrosine group fetuses in the
means of subcutaneous mast cell scales (U=12,
p<0.01**) (Table 4).
Discussion
Colourants must be non-toxic, since they have been
commonly used in foods (8, 9, 10).
Teratogenity is depended on the genetic disposition of
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Figure 3.

A lot of mast cells in dermis of
erythrosine group. Toluidine Blue.

Figure 4.

A lot of mast cells exhibiting
exocytosis in dermis of erythrosine
group. Toluidine Blue.

mother and fetus the expose with teratogen(s) during
development and the dose and time-period of teratogen.
However, the causes of birth defects are largely
unknown, 20-25% of these defects have been derived
from genetic sources (11).
“Critical period” of pregnant rats 7, 8, 9. days of
pregnancy. 0-17 days in human, however, named as
“rezistant period”. In “embryonic period”, 7-57, day of
pregnancy, organ differentiation starts to develop,
therefore this is a very sensitive period in which the
adverse effects of teratogens are frequently seen (12).
Larsson et al. have reported that there was no
significant finding of development retardation in their
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study which investigated the effects of amaranth and
ponceau-4-R. (13). Similarly, Collins et al. have not
observed any difference of average of fetal weights
between control and allura red induced experimental
groups (14). Our findings indicated that organogenesis
period did not exhibit developmental retardation in
erythrosine group. Therefore, it is suggested that
erythrosine did not effective in organogenesis period and
also did not cause any developmental retardation. Our
findings are consistent with the previous studies (13, 14,
15).
Larsson et al. (1975) observed 8% fetal death in
control group in their study which searched the effects of
amaranth and ponceau-4R. These authors the same
parameter was 3.9% in days 0-7, and 12.7% in day 618 in experimental groups (13). In our study, we have
not observed any resorption or fetal death. This findings
are corralated with the previous studies (16, 17).
Larsson et al. observed exencephalic, open eyes and
tail deformities, skeletal anomalies, hydrocephalic,
subcutaneous haemorrhagie and pelvis renalis dilatation
with a very low frequency in their experiment. Collins et
al. also found subcutaneous haemorrhagie in their allura
red study (13, 14). In our study there was no sternal
variation and there was no significant difference between
control and erythrosine groups in the means of skeletal
malformations.
Collins et al. (1992) have found that tartrazine, with
the dose of 100 mg/body weight/day, did not mediated
maternal, teratogenic or fetotoxic effects when
administered by drinking water, suggesting that gavage
methods or drinking water administration might not
change the results (15). In our study resorption, abortus,
neural tube defects, skeletal malformation or sternebral
variation were not observed in fetuses. For this reason,
we conclude that erythrosine administration in the dose
of we used during the organogenesis period of pregnancy
is not teratogenic. It supports other studies (14, 16, 18).
Most atopic diseases, like urticaria, asthma, eczema,
migraine, show food intolerance. It is known that,
cooking or digesting the foods do not cause the entire
loss of antigenic properties. Intake of antigenic food
materials which in protein structure has been known to
cause the reactions like asthma, headache, urticaria,
angioneurotic edema. The food additives, which aimed to
be colourant, preventer of oxidation and enhancer of
taste, causes some allergic reactions. Food intolerance

plays a role in the diseases known as Restaurant Asthma
and Chiniese Restaurant Asthma. Nowadays the increase
in the fast and available food consumption would lead the
increase in the incidence of asthma (17, 18, 19, 20).
In recent years, it has been observed that there is an
increase in the number of the people who suffer from
allergy. A lot of factors acts on the initiation of allergic
reactions but commonly in all of them histamine and
other mediators triggers acute reactions. The number of
mast cells is higher in atopic individuals than that of
normal ones. It has been demonstrated that there is
positive correlation between histamine concentration and
the distribution of mast cells. The trigger mechanism is
known to mediated by mast cells, although histamine and
other mediators are synthesized out of mast cells. The
effectiveness of other cells coincides with later periods
and the sensitivity initiated by mast cells are required (6,
21, 22, 23).
It had been reported that tartrazine, which was used
to give yellow colour to foods and drinks, caused
urticaria, angioneurotic edema, migraine and
gastrointestinal complaints. In the same study, i.v.
administered tartrazine had been shown to mediate a
dose-dependent bornchoconstruction and make mast cells
to degranulated. The relationship between food additives
and nervous system is not only present in tartrazine, but
it also observed in xanthene dyes, for instance
erythrosine, which have been demonstrated that to effect
cholinergic and dopaminergic neuromodulator releases in
neuro-muscular junctions (10).
In our observation, erythrosine increased the number
of mast cells and stimulated the degranulation of these
cells, suggesting that eryhrosine may play an inductive
role in atopic diseases. Therefore, we thought that the
increase in the number of atopic diseases might be
dependent on the gradually increasing consumption of the
foods include additives.
In conclusion, we believe that people must be
informed about the effects of food additives in the
direction of formal regulation. Since food additives make
different effects on different animal species. We believe
that it is necessary to pursue further researchs which
investigates different species with the parameters of
haematology, biochemistry and genotoxicity. We hope our
study would contribute some benefits for consumer
health and especially the prevention of mother’s and
baby’s healths.
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given in drinking water. Food Chem.
Toxicol. 30: 263-68, 1992.

Toxicol. 27: 701-5, 1989.
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